Göran Ahlgren

2.1k total citations
45 papers, 1.2k citations indexed

About

Göran Ahlgren is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Cancer Research. According to data from OpenAlex, Göran Ahlgren has authored 45 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Pulmonary and Respiratory Medicine, 11 papers in Rheumatology and 7 papers in Cancer Research. Recurrent topics in Göran Ahlgren's work include Prostate Cancer Treatment and Research (31 papers), Prostate Cancer Diagnosis and Treatment (27 papers) and Urologic and reproductive health conditions (10 papers). Göran Ahlgren is often cited by papers focused on Prostate Cancer Treatment and Research (31 papers), Prostate Cancer Diagnosis and Treatment (27 papers) and Urologic and reproductive health conditions (10 papers). Göran Ahlgren collaborates with scholars based in Sweden, Denmark and Norway. Göran Ahlgren's co-authors include Jonas Hugosson, Gunnar Aus, Sven Lundberg, K Pedersen, Per‐Anders Abrahamsson, Moddy Schain, Sonny Schelin, Ola Bratt, Svante Bergdahl and Peter Abrahamsson and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and American Journal of Clinical Nutrition.

In The Last Decade

Göran Ahlgren

43 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Göran Ahlgren Sweden	18	943	199	194	174	170	45	1.2k
Peter Hammerer Germany	15	478 0.5×	111 0.6×	155 0.8×	190 1.1×	176 1.0×	52	868
Michael Froehner Germany	18	520 0.6×	178 0.9×	348 1.8×	255 1.5×	172 1.0×	66	1.0k
Sam D. Graham United States	20	715 0.8×	212 1.1×	342 1.8×	280 1.6×	297 1.7×	49	1.3k
Andreas Reissigl Austria	22	1.0k 1.1×	334 1.7×	336 1.7×	227 1.3×	238 1.4×	56	1.4k
Carles X. Raventós Spain	21	850 0.9×	97 0.5×	438 2.3×	174 1.0×	350 2.1×	73	1.4k
Delphine Amsellem‐Ouazana France	19	568 0.6×	115 0.6×	394 2.0×	553 3.2×	158 0.9×	42	1.4k
A. De La Taille France	13	533 0.6×	128 0.6×	142 0.7×	222 1.3×	95 0.6×	56	724
G.L. Andriole United States	12	390 0.4×	166 0.8×	270 1.4×	250 1.4×	87 0.5×	30	867
Friedemann Zengerling Germany	16	339 0.4×	102 0.5×	369 1.9×	207 1.2×	205 1.2×	102	777
Mark H. Kawachi United States	18	552 0.6×	209 1.1×	403 2.1×	232 1.3×	145 0.9×	37	1.1k

Countries citing papers authored by Göran Ahlgren

Since Specialization

Citations

This map shows the geographic impact of Göran Ahlgren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Göran Ahlgren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Göran Ahlgren more than expected).

Fields of papers citing papers by Göran Ahlgren

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Göran Ahlgren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Göran Ahlgren. The network helps show where Göran Ahlgren may publish in the future.

Co-authorship network of co-authors of Göran Ahlgren

This figure shows the co-authorship network connecting the top 25 collaborators of Göran Ahlgren. A scholar is included among the top collaborators of Göran Ahlgren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Göran Ahlgren. Göran Ahlgren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Josefsson, Andreas, Erik Holmberg, Klaus Brasso, et al.. (2023). Effect of docetaxel added to bicalutamide in Hormone-Naïve non-metastatic prostate cancer with rising PSA, a randomized clinical trial (SPCG-14). Acta Oncologica. 62(4). 372–380. 3 indexed citations

Meisgen, Florian, et al.. (2023). Validation of the prognostic value of a three‐gene signature and clinical parameters‐based risk score in prostate cancer patients. The Prostate. 83(12). 1133–1140. 4 indexed citations

Godtman, Rebecka Arnsrud, Erik Persson, Walter Cazzaniga, et al.. (2021). Association of surgeon and hospital volume with short-term outcomes after robot-assisted radical prostatectomy: Nationwide, population-based study. PLoS ONE. 16(6). e0253081–e0253081. 12 indexed citations

Gunnlaugsson, Adalsteinn, Elisabeth Kjellén, Ola Bratt, et al.. (2020). PSA decay during salvage radiotherapy for prostate cancer as a predictor of disease outcome – 5 year follow-up of a prospective observational study. Clinical and Translational Radiation Oncology. 24. 23–28. 5 indexed citations

Cazzaniga, Walter, Rebecka Arnsrud Godtman, Stefan Carlsson, et al.. (2019). Population‐based, nationwide registration of prostatectomies in Sweden. Journal of Surgical Oncology. 120(4). 803–812. 9 indexed citations

Thomsen, Frederik Birkebæk, Fredrik Sandin, Hans Garmo, et al.. (2017). Gonadotropin-releasing Hormone Agonists, Orchiectomy, and Risk of Cardiovascular Disease: Semi-ecologic, Nationwide, Population-based Study. European Urology. 72(6). 920–928. 19 indexed citations

Andersson, G., et al.. (2017). Podocalyxin-like and RNA-binding motif protein 3 are prognostic biomarkers in urothelial bladder cancer: a validatory study. Biomarker Research. 5(1). 10–10. 16 indexed citations

Svensson, Johanna, et al.. (2016). Value of treatment in clinical trials versus the real world: the case of abiraterone acetate (Zytiga) for postchemotherapy metastatic castration-resistant prostate cancer patients in Sweden. Scandinavian Journal of Urology. 50(4). 286–291. 12 indexed citations

Fizazi, Karim, Per‐Anders Abrahamsson, Göran Ahlgren, et al.. (2014). Achievements and Perspectives in Prostate Cancer Phase 3 Trials from Genitourinary Research Groups in Europe: Introducing the Prostate Cancer Consortium in Europe. European Urology. 67(5). 904–912. 14 indexed citations

10.

Bratt, Ola, Rolf Lundgren, & Göran Ahlgren. (2012). [Systematic PSA screening has been tried in Region Skåne. Balanced information gives chance for equal treatment according to a pilot project].. PubMed. 109(37). 1610–2. 1 indexed citations

11.

Kjölhede, Henrik, Göran Ahlgren, Helén Almquist, et al.. (2012). Combined ¹⁸ F‐fluorocholine and ¹⁸ F‐fluoride positron emission tomography/computed tomography imaging for staging of high‐risk prostate cancer. British Journal of Urology. 110(10). 1501–1506. 61 indexed citations

12.

Drake, Isabel, Emily Sonestedt, Bo Gullberg, et al.. (2012). Dietary intakes of carbohydrates in relation to prostate cancer risk: a prospective study in the Malmö Diet and Cancer cohort. American Journal of Clinical Nutrition. 96(6). 1409–1418. 71 indexed citations

13.

Swartling, Johannes, Johan Axelsson, Göran Ahlgren, et al.. (2010). System for interstitial photodynamic therapy with online dosimetry: first clinical experiences of prostate cancer. Journal of Biomedical Optics. 15(5). 58003–58003. 66 indexed citations

14.

Gadaleanu, Virgil, et al.. (2002). Vascular invasion as a marker for prostate cancer recurrence after radical prostatectomy. European Urology Supplements. 1(1). 67–67. 1 indexed citations

15.

Leifsson, Björn Geir, Anders Borgström, & Göran Ahlgren. (2001). Splenic Rupture following ESWL for a Pancreatic Duct Calculus. Digestive Surgery. 18(3). 229–230. 22 indexed citations

16.

Ahlgren, Göran, K Pedersen, Sven Lundberg, et al.. (2000). Regressive changes and neuroendocrine differentiation in prostate cancer after neoadjuvant hormonal treatment. The Prostate. 42(4). 274–279. 72 indexed citations

17.

Ahlgren, Göran, K Pedersen, Sven Lundberg, et al.. (1999). Tumor cell proliferation in prostate cancer after 3 months of neoadjuvant LHRH analogue treatment is a prognostic marker of recurrence after radical prostatectomy. Urology. 54(2). 329–334. 11 indexed citations

18.

Aus, Gunnar, et al.. (1997). Diagnosis of Prostate Cancer: Optimal Number of Prostate Biopsies Related to Serum Prostate-specific Antigen and Findings on Digital Rectal Examination. Scandinavian Journal of Urology and Nephrology. 31(6). 541–544. 12 indexed citations

19.

Ahlgren, Göran, Karin Lindholm, Sture Falkmer, & Per-Anders Abrahamsson. (1997). A dna cytometric proliferation index improves the value of the dna ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate. Urology. 50(3). 379–384. 15 indexed citations

20.

Hugosson, Jonas, Per‐Anders Abrahamsson, Göran Ahlgren, et al.. (1996). The Risk of Malignancy in theSurgical Margin at RadicalProstatectomy Reduced AlmostThree-Fold in Patients GivenNeo-Adjuvant Hormone Treatment. European Urology. 29(4). 413–419. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact